Acute Myocardial Infarction in Women : A Scientific Statement from the American Heart Association

Circulation

Volumn 133, Issue 9, 2016, Pages 916-947

  Mehta, Laxmi S ^a   Beckie, Theresa M ^a   DeVon, Holli A ^a   Grines, Cindy L ^a   Krumholz, Harlan M ^a   Johnson, Michelle N ^a   Lindley, Kathryn J ^a   Vaccarino, Viola ^a   Wang, Tracy Y ^a   Watson, Karol E ^a   Wenger, Nanette K ^a  

^a NONE

Author keywords

AHA Scientific Statements; cardiovascular diseases; coronary disease; myocardial infarction; women

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PRASUGREL; PRAVASTATIN; PURINERGIC P2Y RECEPTOR ANTAGONIST; SIMVASTATIN; TICAGRELOR;

ACUTE HEART INFARCTION; AGE; ANTICOAGULANT THERAPY; BLEEDING; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISSECTION; CORONARY ARTERY SPASM; CORONARY RISK; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EROSION; ETHNIC DIFFERENCE; EXERCISE; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HEART RUPTURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM RUPTURE; HUMAN; HYPERTENSION; MEDICAL SOCIETY; MITRAL VALVE REGURGITATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBESITY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SEXUAL COUNSELING; SEXUAL DYSFUNCTION; SMOKING; SOCIAL PSYCHOLOGY; SPONTANEOUS CORONARY ARTERY DISSECTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; MALE; MYOCARDIAL INFARCTION; SEXUAL DEVELOPMENT; UNITED STATES;

AMERICAN HEART ASSOCIATION; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; SEX CHARACTERISTICS; UNITED STATES; WOMEN;

EID: 84959519569     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000351     Document Type: Review

References (432)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: a report from the American Heart Association [published correction appears in Circulation. 2015;131:e535]. Circulation. 2015;131:e29-e322. doi: 10.1161/CIR.0000000000000152.
2. Gholizadeh L, Davidson P. More similarities than differences: an international comparison of CVD mortality and risk factors in women. Health Care Women Int. 2008;29:3-22. doi: 10.1080/07399330701723756.
3. Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012;126:604-611. doi: 10.1161/CIRCULATIONAHA.111.086892.
4. National Research Council, Institute of Medicine Committee on Understanding the Biology of Sex and Gender Differences. Exploring the Biological Contributions to Human Health: Does Sex Matter Wizemann TM , Pardue M eds. Washington, DC: The National Academies Press; 2001.
5. Institute of Medicine. Women's Health Research: Progress, Pitfalls, and Promise. Washington, DC: National Academies Press; 2010.
6. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G; WISE Investigators. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol. 2006;47(suppl):S21-S29. doi: 10.1016/j.jacc.2004.12.084.
7. Merz CN. The Yentl syndrome is alive and well. Eur Heart J. 2011;32:1313-1315. doi: 10.1093/eurheartj/ehr083.
8. Blomkalns AL, Chen AY, Hochman JS, Peterson ED, Trynosky K, Diercks DB, Brogan GX Jr, Boden WE, Roe MT, Ohman EM, Gibler WB, Newby LK; CRUSADE Investigators. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: largescale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol. 2005;45:832-837. doi: 10.1016/j.jacc.2004.11.055.
9. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, Gaspoz JM; AMIS Plus Investigators. Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart. 2007;93:1369-1375. doi: 10.1136/hrt.2006.106781.
10. Jneid H, Fonarow GC, Cannon CP, Hernandez AF, Palacios IF, Maree AO, Wells Q, Bozkurt B, Labresh KA, Liang L, Hong Y, Newby LK, Fletcher G, Peterson E, Wexler L; on behalf of the Get With the Guidelines Steering Committee and Investigators. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008;118:2803-2810. doi: 10.1161/CIRCULATIONAHA.108.789800.
11. Maynard C, Litwin PE, Martin JS, Weaver WD. Gender differences in the treatment and outcome of acute myocardial infarction: results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med. 1992;152:972-976.
12. Otten AM, Maas AH, Ottervanger JP, Kloosterman A, van 't Hof AW, Dambrink JH, Gosselink AT, Hoorntje JC, Suryapranata H, de Boer MJ; Zwolle Myocardial Infarction study Group. Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent Gender difference in STEMI stratified on age. Eur Heart J Acute Cardiovasc Care. 2013;2:334-341. doi: 10.1177/2048872612475270.
13. Mehilli J, Ndrepepa G, Kastrati A, Nekolla SG, Markwardt C, Bollwein H, Pache J, Martinoff S, Dirschinger J, Schwaiger M, Schömig A. Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol. 2005;45:828-831. doi: 10.1016/j. jacc.2004.11.054.
14. Wijnbergen I, Tijssen J, van 't Veer M, Michels R, Pijls NH. Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction. Catheter Cardiovasc Interv. 2013;82:379-384. doi: 10.1002/ccd.24800.
15. Weaver WD, White HD, Wilcox RG, Aylward PE, Morris D, Guerci A, Ohman EM, Barbash GI, Betriu A, Sadowski Z, Topol EJ, Califf RM. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy: GUSTO-I investigators. JAMA. 1996;275:777-782.
16. D'Onofrio G, Safdar B, Lichtman JH, Strait KM, Dreyer RP, Geda M, Spertus JA, Krumholz HM. Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131:1324-1332. doi: 10.1161/CIRCULATIONAHA.114.012293.
17. Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757-767. doi: 10.1161/CIRCULATIONAHA.114.009480.
18. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM. Sex, clinical presentation, and outcome in patients with acute coronary syndromes: Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med. 1999;341:226-232. doi: 10.1056/NEJM199907223410402.
19. Hochman JS, McCabe CH, Stone PH, Becker RC, Cannon CP, DeFeo-Fraulini T, Thompson B, Steingart R, Knatterud G, Braunwald E. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB: TIMI Investigators: Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 1997;30:141-148.
20. Hasdai D, Porter A, Rosengren A, Behar S, Boyko V, Battler A. Effect of gender on outcomes of acute coronary syndromes. Am J Cardiol. 2003;91:1466-1469, A6.
21. Bellasi A, Raggi P, Merz CN, Shaw LJ. New insights into ischemic heart disease in women. Cleve Clin J Med. 2007;74:585-594.
22. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, Sharaf BL, Sopko G. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999;33:1453-1461.
23. Basso C, Morgagni GL, Thiene G. Spontaneous coronary artery dissection: a neglected cause of acute myocardial ischaemia and sudden death. Heart. 1996;75:451-454.
24. DeMaio SJ Jr, Kinsella SH, Silverman ME. Clinical course and longterm prognosis of spontaneous coronary artery dissection. Am J Cardiol. 1989;64:471-474.
25. Thompson EA, Ferraris S, Gress T, Ferraris V. Gender differences and predictors of mortality in spontaneous coronary artery dissection: a review of reported cases. J Invasive Cardiol. 2005;17:59-61.
26. Selzer A, Langston M, Ruggeroli C, Cohn K. Clinical syndrome of variant angina with normal coronary arteriogram. N Engl J Med. 1976;295:1343-1347. doi: 10.1056/NEJM197612092952403.
27. Dolor RJ, Melloni C, Chatterjee R, Allen Lapointe NM, Williams JB, Coeytaux RR, McBroom AJ, Musty MD, Wing L, Samsa GP, Patel MR. Treatment strategies for women with coronary artery disease: Comparative Effectiveness Review No. 66. Effective Health Care Program: Comparative Effectiveness Review Number 66. 2012. 1-76.
28. Anderson ML, Peterson ED, Brennan JM, Rao SV, Dai D, Anstrom KJ, Piana R, Popescu A, Sedrakyan A, Messenger JC, Douglas PS. Short-and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid Services cohort. Circulation. 2012;126:2190-2199. doi: 10.1161/CIRCULATIONAHA.112.111369.
29. Ahmed B, Dauerman HL. Women, bleeding, and coronary intervention. Circulation. 2013;127:641-649. doi: 10.1161/CIRCULATIONAHA. 112.108290.
30. Poon S, Goodman SG, Yan RT, Bugiardini R, Bierman AS, Eagle KA, Johnston N, Huynh T, Grondin FR, Schenck-Gustafsson K, Yan AT. Bridging the gender gap: insights from a contemporary analysis of sexrelated differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J. 2012;163:66-73. doi: 10.1016/j. ahj.2011.09.025.
31. Wasfy JH, Rosenfield K, Zelevinsky K, Sakhuja R, Lovett A, Spertus JA, Wimmer NJ, Mauri L, Normand SL, Yeh RW. A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes. 2013;6:429-435. doi: 10.1161/CIRCOUTCOMES.111.000093.
32. Levit RD, Reynolds HR, Hochman JS. Cardiovascular disease in young women: a population at risk. Cardiol Rev. 2011;19:60-65. doi: 10.1097/CRD.0b013e31820987b5.
33. Towfighi A, Markovic D, Ovbiagele B. National gender-specific trends in myocardial infarction hospitalization rates among patients aged 35 to 64 years. Am J Cardiol. 2011;108:1102-1107. doi: 10.1016/j. amjcard.2011.05.046.
34. Gupta A, Wang Y, Spertus JA, Geda M, Lorenze N, Nkonde-Price C, D'Onofrio G, Lichtman JH, Krumholz HM. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64:337-345. doi: 10.1016/j.jacc.2014.04.054.
35. Dreyer RP, Ranasinghe I, Wang Y, Dharmarajan K, Murugiah K, Nuti SV, Hsieh AF, Spertus JA, Krumholz HM. Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation. 2015;132:158-166. doi: 10.1161/CIRCULATIONAHA.114.014776.
36. National Center for Health Statistics. Health, United States, 2011: With Special Feature on Socioeconomic Status and Health. 2012. http://www. cdc.gov/nchs/data/hus/hus11.pdf. Accessed November 4, 2015.
37. Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sexbased differences in early mortality after myocardial infarction: National Registry of Myocardial Infarction 2 Participants. N Engl J Med. 1999;341:217-225. doi: 10.1056/NEJM199907223410401.
38. Vaccarino V, Horwitz RI, Meehan TP, Petrillo MK, Radford MJ, Krumholz HM. Sex differences in mortality after myocardial infarction: evidence for a sex-age interaction. Arch Intern Med. 1998;158:2054-2062.
39. Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med. 2001;134:173-181.
40. Zhang Z, Fang J, Gillespie C, Wang G, Hong Y, Yoon PW. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012;109:1097-1103. doi: 10.1016/j. amjcard.2011.12.001.
41. Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ; NRMI Investigators. Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813-822. doi: 10.1001/jama.2012.199.
42. Egiziano G, Akhtari S, Pilote L, Daskalopoulou SS; GENESIS (GENdEr and Sex DetermInants of Cardiovascular Disease) Investigators. Sex differences in young patients with acute myocardial infarction. Diabet Med. 2013;30:e108-e114. doi: 10.1111/dme.12084.
43. Champney KP, Frederick PD, Bueno H, Parashar S, Foody J, Merz CN, Canto JG, Lichtman JH, Vaccarino V; NRMI Investigators. The joint contribution of sex, age and type of myocardial infarction on hospital mortality following acute myocardial infarction. Heart. 2009;95:895-899. doi: 10.1136/hrt.2008.155804.
44. Claassen M, Sybrandy KC, Appelman YE, Asselbergs FW. Gender gap in acute coronary heart disease: myth or reality World J Cardiol. 2012;4:36-47. doi: 10.4330/wjc.v4.i2.36.
45. Nohria A, Vaccarino V, Krumholz HM. Gender differences in mortality after myocardial infarction: why women fare worse than men. Cardiol Clin. 1998;16:45-57.
46. Vaccarino V, Krumholz HM, Berkman LF, Horwitz RI. Sex differences in mortality after myocardial infarction: is there evidence for an increased risk for women Circulation. 1995;91:1861-1871.
47. Beckie TM. Biopsychosocial determinants of health and quality of life among young women with coronary heart disease. Curr Cardiovasc Risk Reps. 2013;8:1-10.
48. Lichtman JH, Lorenze NP, D'Onofrio G, Spertus JA, Lindau ST, Morgan TM, Herrin J, Bueno H, Mattera JA, Ridker PM, Krumholz HM. Variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study design. Circ Cardiovasc Qual Outcomes. 2010;3:684-693. doi: 10.1161/CIRCOUTCOMES.109.928713.
49. Chakrabarti S, Morton JS, Davidge ST. Mechanisms of estrogen effects on the endothelium: an overview. Can J Cardiol. 2014;30:705-712. doi: 10.1016/j.cjca.2013.08.006.
50. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension. 2005;46:249-254. doi: 10.1161/01. HYP.0000172945.06681.a4.
51. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811. doi: 10.1056/NEJM199906103402306.
52. Hermenegildo C, Oviedo PJ, Cano A. Cyclooxygenases regulation by estradiol on endothelium. Curr Pharm Des. 2006;12:205-215.
53. Mercuro G, Longu G, Zoncu S, Cherchi A. Impaired forearm blood flow and vasodilator reserve in healthy postmenopausal women. Am Heart J. 1999;137(pt 1):692-697.
54. Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10(suppl 1):19-24. doi: 10.1080/13697130601114917.
55. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576-582.
56. Rossouw JE, Manson JE, Kaunitz AM, Anderson GL. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol. 2013;121:172-176. doi: http://10.1097/AOG.0b013e31827a08c8.
57. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pinã IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association [published correction appears in Circulation. 2011;123:e624 and Circulation. 2011;124:e427]. Circulation. 2011;123:1243-1262. doi: 10.1161/CIR.0b013e31820faaf8.
58. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED; American College of Cardiology-National Cardiovascular Data Registry Investigators. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117:1787-1801. doi: 10.1161/CIRCULATIONAHA.107.726562.
59. Mehta RH, Marks D, Califf RM, Sohn S, Pieper KS, Van de Werf F, Peterson ED, Ohman EM, White HD, Topol EJ, Granger CB. Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction. Am J Med. 2006;119:70.e1-70.e8. doi: 10.1016/j. amjmed.2005.07.043.
60. Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects: Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007;167:573-579. doi: 10.1001/archinte.167.6.573.
61. Clark LT, Ferdinand KC, Flack JM, Gavin JR 3rd, Hall WD, Kumanyika SK, Reed JW, Saunders E, Valantine HA, Watson K, Wenger NK, Wright JT. Coronary heart disease in African Americans. Heart Dis. 2001;3:97-108.
62. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G; REGARDS Investigators. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308:1768-1774. doi: 10.1001/jama.2012.14306.
63. Burke AP, Farb A, Pestaner J, Malcom GT, Zieske A, Kutys R, Smialek J, Virmani R. Traditional risk factors and the incidence of sudden coronary death with and without coronary thrombosis in blacks. Circulation. 2002;105:419-424.
64. Becker LB, Han BH, Meyer PM, Wright FA, Rhodes KV, Smith DW, Barrett J. Racial differences in the incidence of cardiac arrest and subsequent survival: the CPR Chicago Project. N Engl J Med. 1993;329:600-606. doi: 10.1056/NEJM199308263290902.
65. Chan PS, Nichol G, Krumholz HM, Spertus JA, Jones PG, Peterson ED, Rathore SS, Nallamothu BK; American Heart Association National Registry of Cardiopulmonary Resuscitation (NRCPR) Investigators. Racial differences in survival after in-hospital cardiac arrest. JAMA. 2009;302:1195-1201. doi: 10.1001/jama.2009.1340.
66. Jose PO, Frank AT, Kapphahn KI, Goldstein BA, Eggleston K, Hastings KG, Cullen MR, Palaniappan LP. Cardiovascular disease mortality in Asian Americans. J Am Coll Cardiol. 2014;64:2486-2494. doi: 10.1016/j. jacc.2014.08.048.
67. Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups. Ann Epidemiol. 2011;21:608-614. doi: 10.1016/j.annepidem.2011.04.004.
68. Palaniappan LP, Araneta MR, Assimes TL, Barrett-Connor EL, Carnethon MR, Criqui MH, Fung GL, Narayan KM, Patel H, Taylor-Piliae RE, Wilson PW, Wong ND; on behalf of the American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; Council on Cardiovascular Nursing. Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association [published correction appears in Circulation. 2010;122:e516]. Circulation. 2010;122:1242-1252. doi: 10.1161/CIR.0b013e3181f22af4.
69. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S, Yusuf S. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297:286-294. doi: 10.1001/jama.297.3.286.
70. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG. Differences in medical care and disease outcomes among black and white women with heart disease. Circulation. 2003;108:1089-1094. doi: 10.1161/01.CIR.0000085994.38132.E5.
71. Rodriguez CJ, Allison M, Daviglus ML, Isasi CR, Keller C, Leira EC, Palaniappan L, Pinã IL, Ramirez SM, Rodriguez B, Sims M; on behalf of the American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular and Stroke Nursing. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593-625. doi: 10.1161/CIR.0000000000000071.
72. Leifheit-Limson EC, Spertus JA, Reid KJ, Jones SB, Vaccarino V, Krumholz HM, Lichtman JH. Prevalence of traditional cardiac risk factors and secondary prevention among patients hospitalized for acute myocardial infarction (AMI): variation by age, sex, and race. J Womens Health (Larchmt). 2013;22:659-666. doi: 10.1089/jwh.2012.3962.
73. Nichaman MZ, Wear ML, Goff DC Jr, Labarthe DR. Hospitalization rates for myocardial infarction among Mexican-Americans and non-Hispanic whites: the Corpus Christi Heart Project. Ann Epidemiol. 1993;3:42-48.
74. Centers for Disease Control and Prevention (CDC). Health status of American Indians compared with other racial/ethnic minority populations: selected states, 2001-2002. MMWR Morb Mortal Wkly Rep. 2003;52:1148-1152.
75. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, Howard WJ, Rhoades ER, Robbins DC, Sievers ML, Welty TK. Rising tide of cardiovascular disease in American Indians: the Strong Heart Study. Circulation. 1999;99:2389-2395.
76. Best LG, Butt A, Conroy B, Devereux RB, Galloway JM, Jolly S, Lee ET, Silverman A, Yeh JL, Welty TK, Kedan I. Acute myocardial infarction quality of care: the Strong Heart Study. Ethn Dis. 2011;21:294-300.
77. Lee ET, Cowan LD, Welty TK, Sievers M, Howard WJ, Oopik A, Wang W, Yeh J, Devereux RB, Rhoades ER, Fabsitz RR, Go O, Howard BV. Allcause mortality and cardiovascular disease mortality in three American Indian populations, aged 45-74 years, 1984-1988: the Strong Heart Study. Am J Epidemiol. 1998;147:995-1008.
78. Manhapra A, Canto JG, Vaccarino V, Parsons L, Kiefe CI, Barron HV, Rogers WJ, Weaver WD, Borzak S. Relation of age and race with hospital death after acute myocardial infarction. Am Heart J. 2004;148:92-98. doi: 10.1016/j.ahj.2004.02.010.
79. Vaccarino V, Rathore SS, Wenger NK, Frederick PD, Abramson JL, Barron HV, Manhapra A, Mallik S, Krumholz HM; National Registry of Myocardial Infarction Investigators. Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med. 2005;353:671-682. doi: 10.1056/NEJMsa032214.
80. Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988-1994: Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109-116.
81. Wang OJ, Wang Y, Chen J, Krumholz HM. Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol. 2012;109:1589-1593. doi: 10.1016/j.amjcard.2012.01.381.
82. Chen J, Normand SL, Wang Y, Drye EE, Schreiner GC, Krumholz HM. Recent declines in hospitalizations for acute myocardial infarction for Medicare feefor-service beneficiaries: progress and continuing challenges. Circulation. 2010;121:1322-1328. doi: 10.1161/CIRCULATIONAHA.109.862094.
83. Canto JG, Taylor HA Jr, Rogers WJ, Sanderson B, Hilbe J, Barron HV. Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the National Registry of Myocardial Infarction 2. Am J Cardiol. 1998;82:1013-1018.
84. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269:2642-2646.
85. Chen J, Rathore SS, Radford MJ, Wang Y, Krumholz HM. Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med. 2001;344:1443-1449. doi: 10.1056/NEJM200105103441906.
86. Mitchell BD, González Villalpando C, Arredondo Pérez B, Garciá MS, Valdez R, Stern MP. Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vasc Biol. 1995;15:721-725.
87. Correa-de-Araujo R, Stevens B, Moy E, Nilasena D, Chesley F, McDermott K. Gender differences across racial and ethnic groups in the quality of care for acute myocardial infarction and heart failure associated with comorbidities. Womens Health Issues. 2006;16:44-55.
88. Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G. Racial/ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation. 2014;129:754-763. doi: 10.1161/CIRCULATIONAHA.113.002658.
89. Glickman SW, Granger CB, Ou FS, O'Brien S, Lytle BL, Cairns CB, Mears G, Hoekstra JW, Garvey JL, Peterson ED, Jollis JG. Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly. Circ Cardiovasc Qual Outcomes. 2010;3:514-521. doi: 10.1161/CIRCOUTCOMES.109.917112.
90. Cohen MG, Fonarow GC, Peterson ED, Moscucci M, Dai D, Hernandez AF, Bonow RO, Smith SC Jr. Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation. 2010;121:2294-2301. doi: 10.1161/CIRCULATIONAHA.109.922286.
91. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J. 2013;34:719-728. doi: 10.1093/eurheartj/ehs411.
92. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50:127-134.
93. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
94. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
95. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(suppl):C13-C18. doi: 10.1016/j. jacc.2005.10.065.
96. Schwartz RS, Burke A, Farb A, Kaye D, Lesser JR, Henry TD, Virmani R. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J Am Coll Cardiol. 2009;54:2167-2173. doi: 10.1016/j. jacc.2009.07.042.
97. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354-1363.
98. Chokshi NP, Iqbal SN, Berger RL, Hochman JS, Feit F, Slater JN, Pena-Sing I, Yatskar L, Keller NM, Babaev A, Attubato MJ, Reynolds HR. Sex and race are associated with the absence of epicardial coronary artery obstructive disease at angiography in patients with acute coronary syndromes. Clin Cardiol. 2010;33:495-501. doi: 10.1002/clc.20794.
99. Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Topol EJ, Hochman JS, Newby LK, Harrington RA, Califf RM, Becker RC, Douglas PS. Sex differences in mortality following acute coronary syndromes. JAMA. 2009;302:874-882. doi: 10.1001/jama.2009.1227.
100. Prati F, Uemura S, Souteyrand G, Virmani R, Motreff P, Di Vito L, Biondi-Zoccai G, Halperin J, Fuster V, Ozaki Y, Narula J. OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging. 2013;6:283-287. doi: 10.1016/j.jcmg.2012.12.007.
101. Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, Tomobuchi Y, Akasaka T. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933-939. doi: 10.1016/j.jacc.2007.04.082.
102. Jia H, Abtahian F, Aguirre AD, Lee S, Chia S, Lowe H, Kato K, Yonetsu T, Vergallo R, Hu S, Tian J, Lee H, Park SJ, Jang YS, Raffel OC, Mizuno K, Uemura S, Itoh T, Kakuta T, Choi SY, Dauerman HL, Prasad A, Toma C, McNulty I, Zhang S, Yu B, Fuster V, Narula J, Virmani R, Jang IK. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748-1758. doi: 10.1016/j.jacc.2013.05.071.
103. Guagliumi G, Capodanno D, Saia F, Musumeci G, Tarantini G, Garbo R, Tumminello G, Sirbu V, Coccato M, Fineschi M, Trani C, De Benedictis M, Limbruno U, De Luca L, Niccoli G, Bezerra H, Ladich E, Costa M, Biondi Zoccai G, Virmani R; OCTAVIA Trial Investigators. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv. 2014;7:958-968. doi: 10.1016/j.jcin.2014.05.011.
104. Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83:361-366.
105. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276-1282. doi: 10.1056/NEJM199705013361802.
106. Burke AP, Farb A, Malcom GT, Liang Y, Smialek J, Virmani R. Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97:2110-2116.
107. Bøttcher M, Falk E. Pathology of the coronary arteries in smokers and non-smokers. J Cardiovasc Risk. 1999;6:299-302.
108. Davies MJ. The composition of coronary-artery plaques. N Engl J Med. 1997;336:1312-1314. doi: 10.1056/NEJM199705013361809.
109. Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, Ohman EM, Newby LK, Peterson ED, Hochman JS. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009;158:688-694. doi: 10.1016/j.ahj.2009.08.004.
110. Reynolds HR, Srichai MB, Iqbal SN, Slater JN, Mancini GB, Feit F, Pena-Sing I, Axel L, Attubato MJ, Yatskar L, Kalhorn RT, Wood DA, Lobach IV, Hochman JS. Mechanisms of myocardial infarction in women without angiographically obstructive coronary artery disease. Circulation. 2011;124:1414-1425. doi: 10.1161/CIRCULATIONAHA. 111.026542.
111. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Interv. 2009;2:482-490. doi: 10.1161/CIRCINTERVENTIONS.109.868398.
112. Spatz ES, Curry LA, Masoudi FA, Zhou S, Strait KM, Gross CP, Curtis JP, Lansky AJ, Soares Barreto-Filho JA, Lampropulos JF, Bueno H, Chaudhry SI, D'Onofrio G, Safdar B, Dreyer RP, Murugiah K, Spertus JA, Krumholz HM. The Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) classification system: a taxonomy for young women with acute myocardial infarction. Circulation. 2015;132:1710-1718. doi: 10.1161/CIRCULATIONAHA.115.016502.
113. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris, I: a variant form of angina pectoris; preliminary report. Am J Med. 1959;27:375-388.
114. Nakayama N, Kaikita K, Fukunaga T, Matsuzawa Y, Sato K, Horio E, Yoshimura H, Mizobe M, Takashio S, Tsujita K, Kojima S, Tayama S, Hokimoto S, Sakamoto T, Nakao K, Sugiyama S, Kimura K, Ogawa H. Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome. J Am Heart Assoc. 2014;3:e000795. doi: 10.1161/JAHA.114.000795.
115. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2008;52:523-527. doi: 10.1016/j. jacc.2008.04.050.
116. Stern S, Bayes de Luna A. Coronary artery spasm: a 2009 update. Circulation. 2009;119:2531-2534. doi: 10.1161/CIRCULATIONAHA.108.843474.
117. Lanza GA, Careri G, Crea F. Mechanisms of coronary artery spasm. Circulation. 2011;124:1774-1782. doi: 10.1161/CIRCULATIONAHA. 111.037283.
118. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87:76-79.
119. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol. 1996;28:1249-1256. doi: 10.1016/S0735-1097(96)00309-9.s
120. Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562. doi: 10.1056/NEJM198912073212301.
121. Enders JM, Dobesh PP, Ellison JN. Acute myocardial infarction induced by ephedrine alkaloids. Pharmacotherapy. 2003;23:1645-1651.
122. Shimizu M, Hata K, Takaoka H, Kanazawa K, Shinke T, Matsumoto H, Watanabe S, Yoshikawa R, Masai H, Miyamoto Y, Akita H, Yokoyama M. Sumatriptan provokes coronary artery spasm in patients with variant angina: possible involvement of serotonin 1B receptor. Int J Cardiol. 2007;114:188-194. doi: 10.1016/j.ijcard.2006.01.026.
123. Tobbia P, Norris LA, Klima LD. Ventricular fibrillation coinciding with phentermine initiation. BMJ Case Rep. 2012;2012. doi: 10.1136/bcr-2012-006410.
124. Magarian GJ, Mazur DJ. The hyperventilation challenge test: another means of identifying coronary vasospasm in patients with angina-like chest pain. Chest. 1991;99:199-204.
125. Yamada T, Okamoto M, Sueda T, Hashimoto M, Matsuura H, Kajiyama G. Ergonovine-induced alterations in coronary flow velocity preceding onset of occlusive spasm in patients without significant coronary artery stenoses. Am J Cardiol. 1998;81:688-693.
126. Ong P, Athanasiadis A, Borgulya G, Vokshi I, Bastiaenen R, Kubik S, Hill S, Schaüfele T, Mahrholdt H, Kaski JC, Sechtem U. Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation. 2014;129:1723-1730. doi: 10.1161/CIRCULATIONAHA.113.004096.
127. Kawana A, Takahashi J, Takagi Y, Yasuda S, Sakata Y, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Kubo N, Momomura S, Ogawa H, Shimokawa H; Japanese Coronary Spasm Association. Gender differences in the clinical characteristics and outcomes of patients with vasospastic angina: a report from the Japanese Coronary Spasm Association. Circ J. 2013;77:1267-1274.
128. Ozaki Y, Keane D, Serruys PW. Progression and regression of coronary stenosis in the long-term follow-up of vasospastic angina. Circulation. 1995;92:2446-2456.
129. Oshima S, Yasue H, Ogawa H, Okumura K, Matsuyama K. Fibrinopeptide A is released into the coronary circulation after coronary spasm. Circulation. 1990;82:2222-2225.
130. Masuda T, Ogawa H, Miyao Y, Yu Q, Misumi I, Sakamoto T, Okubo H, Okumura K, Yasue H. Circadian variation in fibrinolytic activity in patients with variant angina. Br Heart J. 1994;71:156-161.
131. Wakabayashi K, Suzuki H, Honda Y, Wakatsuki D, Kawachi K, Ota K, Koba S, Shimizu N, Asano F, Sato T, Takeyama Y. Provoked coronary spasm predicts adverse outcome in patients with acute myocardial infarction: a novel predictor of prognosis after acute myocardial infarction. J Am Coll Cardiol. 2008;52:518-522. doi: 10.1016/j.jacc.2008.01.076.
132. Ong P, Athanasiadis A, Borgulya G, Voehringer M, Sechtem U. 3-Year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) study follow-up. J Am Coll Cardiol. 2011;57:147-152. doi: 10.1016/j.jacc.2010.08.626.
133. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries: long-term follow-up of 277 patients. Eur Heart J. 1996;17:1015-1021.
134. Vrints CJ. Spontaneous coronary artery dissection. Heart. 2010;96:801-808. doi: 10.1136/hrt.2008.162073.
135. Vanzetto G, Berger-Coz E, Barone-Rochette G, Chavanon O, Bouvaist H, Hacini R, Blin D, Machecourt J. Prevalence, therapeutic management and medium-term prognosis of spontaneous coronary artery dissection: results from a database of 11,605 patients. Eur J Cardiothorac Surg. 2009;35:250-254. doi: 10.1016/j.ejcts.2008.10.023.
136. Nishiguchi T, Tanaka A, Ozaki Y, Taruya A, Fukuda S, Taguchi H, Iwaguro T, Ueno S, Okumoto Y, Akasaka T. Prevalence of spontaneous coronary artery dissection in patients with acute coronary syndrome [published online ahead of print September 11, 2013]. Eur Heart J Acute Cardiovasc Care. doi:10.1177/2048872613504310. http://acc.sagepub.com/content/early/2013/09/11/2048872613504310.long. Accessed November 4, 2015.
137. Alfonso F, Paulo M, Lennie V, Dutary J, Bernardo E, Jiménez-Quevedo P, Gonzalo N, Escaned J, Bañuelos C, Pérez-Vizcayno MJ, Hernández R, Macaya C. Spontaneous coronary artery dissection: long-term follow-up of a large series of patients prospectively managed with a "conservative" therapeutic strategy. JACC Cardiovasc Interv. 2012;5:1062-1070. doi: 10.1016/j.jcin.2012.06.014.
138. Tweet MS, Hayes SN, Pitta SR, Simari RD, Lerman A, Lennon RJ, Gersh BJ, Khambatta S, Best PJ, Rihal CS, Gulati R. Clinical features, management, and prognosis of spontaneous coronary artery dissection. Circulation. 2012;126:579-588. doi: 10.1161/CIRCULATIONAHA.112.105718.
139. Michelis KC, Olin JW, Kadian-Dodov D, d'Escamard V, Kovacic JC. Coronary artery manifestations of fibromuscular dysplasia. J Am Coll Cardiol. 2014;64:1033-1046. doi: 10.1016/j.jacc.2014.07.014.
140. Saw J, Ricci D, Starovoytov A, Fox R, Buller CE. Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. JACC Cardiovasc Interv. 2013;6:44-52. doi: 10.1016/j.jcin.2012.08.017.
141. Tashtoush B, Balagadde A, Bhatt M. Spontaneous coronary artery dissection with multiple coronary artery aneurysms in a patient with diabetic ketoacidosis. J Thorac Dis. 2014;6:E5-E10. doi: 10.3978/j. issn.2072-1439.2013.12.37.
142. Shamloo BK, Chintala RS, Nasur A, Ghazvini M, Shariat P, Diggs JA, Singh SN. Spontaneous coronary artery dissection: aggressive vs. conservative therapy. J Invasive Cardiol. 2010;22:222-228.
143. Trabattoni D, Calligaris A, Bartorelli AL. Images in cardiovascular medicine: fast and complete healing of 2 coronary artery spontaneous dissections. Circulation. 2005;111:e282. doi: 10.1161/01. CIR.0000164202.85285.DF.
144. Sarmento-Leite R, Machado PR, Garcia SL. Spontaneous coronary artery dissection: stent it or wait for healing Heart. 2003;89:164.
145. Mortensen KH, Thuesen L, Kristensen IB, Christiansen EH. Spontaneous coronary artery dissection: a Western Denmark Heart Registry study. Catheter Cardiovasc Interv. 2009;74:710-717. doi: 10.1002/ccd.22115.
146. Tweet MS, Eleid MF, Best PJ, Lennon RJ, Lerman A, Rihal CS, Holmes DR Jr, Hayes SN, Gulati R. Spontaneous coronary artery dissection: revascularization versus conservative therapy. Circ Cardiovasc Interv. 2014;7:777-786. doi: 10.1161/CIRCINTERVENTIONS.114.001659.
147. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952. doi: 10.1016/S0140-6736(04)17018-9.
148. Daviglus ML, Stamler J, Pirzada A, Yan LL, Garside DB, Liu K, Wang R, Dyer AR, Lloyd-Jones DM, Greenland P. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA. 2004;292:1588-1592. doi: 10.1001/jama.292.13.1588.
149. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104-1109.
150. Dreyer RP, Smolderen KG, Strait KM, Beltrame JF, Lichtman JH, Lorenze NP, D'Onofrio G, Bueno H, Krumholz HM, Spertus JA. Gender differences in pre-event health status of young patients with acute myocardial infarction: a VIRGO study analysis [published online ahead of print on February 13, 2015]. Eur Heart J Acute Cardiovasc Care. doi: 10.1177/2048872615568967. http://acc.sagepub.com/content/early/2015/02/12/2048872615568967.long. Accessed November 4, 2015.
151. Lichtman JH, Leifheit-Limson EC, Watanabe E, Allen NB, Garavalia B, Garavalia LS, Spertus JA, Krumholz HM, Curry LA. Symptom recognition and healthcare experiences of young women with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015;8(suppl 1):S31-S38. doi: 10.1161/CIRCOUTCOMES.114.001612.
152. Njølstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction: a 12-year followup of the Finnmark Study. Circulation. 1996;93:450-456.
153. Reibis R, Treszl A, Wegscheider K, Bestehorn K, Karmann B, Völler H. Disparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patients. Vasc Health Risk Manag. 2012;8:473-481. doi: 10.2147/VHRM.S33305.
154. Bangalore S, Fonarow GC, Peterson ED, Hellkamp AS, Hernandez AF, Laskey W, Peacock WF, Cannon CP, Schwamm LH, Bhatt DL; on behalf of the Get with the Guidelines Steering Committee and Investigators. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012;125:1000-1009. doi: 10.1016/j.amjmed.2011.11.016.
155. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Hunter DJ, Hennekens CH, Speizer FE. Smoking cessation in relation to total mortality rates in women: a prospective cohort study. Ann Intern Med. 1993;119:992-1000.
156. Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med. 1987;317:1303-1309. doi: 10.1056/NEJM198711193172102.
157. US Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the Surgeon General. 2014. http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf. Accessed November 4, 2015.
158. van der Giezen AM, Schopman-Geurts van Kessel JG, Schouten EG, Slotboom BJ, Kok FJ, Collette HJ. Systolic blood pressure and cardiovascular mortality among 13,740 Dutch women. Prev Med. 1990;19:456-465.
159. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. doi: 10.1161/01. HYP.0000252676.46043.18.
160. Ostchega Y, Yoon SS, Hughes J, Louis T. Hypertension awareness, treatment, and control: continued disparities in adults: United States, 2005-2006. NCHS Data Brief. 2008:1-8.
161. Manolio TA, Pearson TA, Wenger NK, Barrett-Connor E, Payne GH, Harlan WR. Cholesterol and heart disease in older persons and women: review of an NHLBI workshop. Ann Epidemiol. 1992;2:161-176.
162. Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004;110:2824-2830. doi: 10.1161/01.CIR.0000146339.57154.9B.
163. Reddy VS, Bui QT, Jacobs JR, Begelman SM, Miller DP, French WJ; Investigators of National Registry of Myocardial Infarction (NRMI) 4b-5. Relationship between serum low-density lipoprotein cholesterol and in-hospital mortality following acute myocardial infarction (the lipid paradox). Am J Cardiol. 2015;115:557-562. doi: 10.1016/j. amjcard.2014.12.006.
164. Cheng KH, Chu CS, Lin TH, Lee KT, Sheu SH, Lai WT. Lipid paradox in acute myocardial infarction: the association with 30-day inhospital mortality. Crit Care Med. 2015;43:1255-1264. doi: 10.1097/CCM.0000000000000946.
165. Flanders WD, Eldridge RC, McClellan W. A nearly unavoidable mechanism for collider bias with index-event studies. Epidemiology. 2014;25:762-764. doi: 10.1097/EDE.0000000000000131.
166. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295:1549-1555. doi: 10.1001/jama.295.13.1549.
167. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806-814. doi: 10.1001/jama.2014.732.
168. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE. Body weight and mortality among women. N Engl J Med. 1995;333:677-685. doi: 10.1056/NEJM199509143331101.
169. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med. 2002;162:1737-1745.
170. Mente A, Yusuf S, Islam S, McQueen MJ, Tanomsup S, Onen CL, Rangarajan S, Gerstein HC, Anand SS; INTERHEART Investigators. Metabolic syndrome and risk of acute myocardial infarction a casecontrol study of 26,903 subjects from 52 countries. J Am Coll Cardiol. 2010;55:2390-2398. doi: 10.1016/j.jacc.2009.12.053.
171. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men The Rancho Bernardo Study [published correction appears in JAMA. 1991;265:3249]. JAMA. 1991;265:627-631.
172. Kalyani RR, Lazo M, Ouyang P, Turkbey E, Chevalier K, Brancati F, Becker D, Vaidya D. Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care. 2014;37:830-838. doi: 10.2337/dc13-1755.
173. Donahoe SM, Stewart GC, McCabe CH, Mohanavelu S, Murphy SA, Cannon CP, Antman EM. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765-775. doi: 10.1001/jama.298.7.765.
174. Xu X, Bao H, Strait K, Spertus JA, Lichtman JH, D'Onofrio G, Spatz E, Bucholz EM, Geda M, Lorenze NP, Bueno H, Beltrame JF, Krumholz HM. Sex differences in perceived stress and early recovery in young and middle-aged patients with acute myocardial infarction. Circulation. 2015;131:614-623. doi: 10.1161/CIRCULATIONAHA.114.012826.
175. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings. 2012. http://www.samhsa.gov/data/sites/default/files/2011MHFDT/2k11MHFR/Web/NSDUHmhfr2011.htm. Accessed November 4, 2015.
176. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women: the Women's Health Initiative (WHI). Arch Intern Med. 2004;164:289-298. doi: 10.1001/archinte.164.3.289.
177. Whang W, Kubzansky LD, Kawachi I, Rexrode KM, Kroenke CH, Glynn RJ, Garan H, Albert CM. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol. 2009;53:950-958. doi: 10.1016/j. jacc.2008.10.060.
178. Shah AJ, Veledar E, Hong Y, Bremner JD, Vaccarino V. Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. Arch Gen Psychiatry. 2011;68:1135-1142. doi: 10.1001/archgenpsychiatry.2011.125.
179. Smolderen KG, Strait KM, Dreyer RP, D'Onofrio G, Zhou S, Lichtman JH, Geda M, Bueno H, Beltrame J, Safdar B, Krumholz HM, Spertus JA. Depressive symptoms in younger women and men with acute myocardial infarction: insights from the VIRGO study. J Am Heart Assoc. 2015;4.e001424. doi:10.1161/JAHA.114.001424.
180. Rich-Edwards JW, Mason S, Rexrode K, Spiegelman D, Hibert E, Kawachi I, Jun HJ, Wright RJ. Physical and sexual abuse in childhood as predictors of early-onset cardiovascular events in women. Circulation. 2012;126:920-927. doi: 10.1161/CIRCULATIONAHA.111.076877.
181. Korkeila J, Vahtera J, Korkeila K, Kivimäki M, Sumanen M, Koskenvuo K, Koskenvuo M. Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease. Heart. 2010;96:298-303. doi: 10.1136/hrt.2009.188250.
182. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010;56:38-46. doi: 10.1016/j.jacc.2010.03.034.
183. Hemingway H, Langenberg C, Damant J, Frost C, Pyörälä K, Barrett-Connor E. Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation. 2008;117:1526-1536. doi: 10.1161/CIRCULATIONAHA.107.720953.
184. Khan NA, Daskalopoulou SS, Karp I, Eisenberg MJ, Pelletier R, Tsadok MA, Dasgupta K, Norris CM, Pilote L; GENESIS PRAXY Team. Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013;173:1863-1871. doi: 10.1001/jamainternmed.2013.10149.
185. Rubini Gimenez M, Reiter M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Wicki K, Zellweger C, Hoeller R, Moehring B, Sou SM, Mueller M, Denhaerynck K, Meller B, Stallone F, Henseler S, Bassetti S, Geigy N, Osswald S, Mueller C. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. JAMA Intern Med. 2014;174:241-249. doi: 10.1001/jamainternmed.2013.12199.
186. Wenger NK. Angina in women. Curr Cardiol Rep. 2010;12:307-314. doi: 10.1007/s11886-010-0111-z.
187. McSweeney JC, Cleves MA, Zhao W, Lefler LL, Yang S. Cluster analysis of women's prodromal and acute myocardial infarction symptoms by race and other characteristics. J Cardiovasc Nurs. 2010;25:311-322. doi: 10.1097/JCN.0b013e3181cfba15.
188. DeVon HA, Ryan CJ, Ochs AL, Shapiro M. Symptoms across the continuum of acute coronary syndromes: differences between women and men. Am J Crit Care. 2008;17:14-24; quiz 25.
189. Noureddine S, Arevian M, Adra M, Puzantian H. Response to signs and symptoms of acute coronary syndrome: differences between Lebanese men and women. Am J Crit Care. 2008;17:26-35.
190. Arslanian-Engoren C, Patel A, Fang J, Armstrong D, Kline-Rogers E, Duvernoy CS, Eagle KA. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol. 2006;98:1177-1181. doi: 10.1016/j.amjcard.2006.05.049.
191. Løvlien M, Schei B, Gjengedal E. Are there gender differences related to symptoms of acute myocardial infarction A Norwegian perspective. Prog Cardiovasc Nurs. 2006;21:14-19.
192. O'Donnell S, McKee G, Mooney M, O'Brien F, Moser DK. Slow-onset and fast-onset symptom presentations in acute coronary syndrome (ACS): new perspectives on prehospital delay in patients with ACS. J Emerg Med. 2014;46:507-515. doi: 10.1016/j.jemermed.2013.08.038.
193. McSweeney JC, O'Sullivan P, Cleves MA, Lefler LL, Cody M, Moser DK, Dunn K, Kovacs M, Crane PB, Ramer L, Messmer PR, Garvin BJ, Zhao W. Racial differences in women's prodromal and acute symptoms of myocardial infarction. Am J Crit Care. 2010;19:63-73. doi: 10.4037/ajcc2010372.
194. Devon HA, Rosenfeld A, Steffen AD, Daya M. Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist. J Am Heart Assoc. 2014;3:e000586. doi: 10.1161/JAHA.113.000586.
195. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G; Women's Ischemia Syndrome Evaluation (WISE) Investigators. The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation. 2006;114:894-904. doi: 10.1161/CIRCULATIONAHA.105.609990.
196. Ting HH, Bradley EH, Wang Y, Lichtman JH, Nallamothu BK, Sullivan MD, Gersh BJ, Roger VL, Curtis JP, Krumholz HM. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med. 2008;168:959-968. doi: 10.1001/archinte.168.9.959.
197. Chugh SS, Jui J, Gunson K, Stecker EC, John BT, Thompson B, Ilias N, Vickers C, Dogra V, Daya M, Kron J, Zheng ZJ, Mensah G, McAnulty J. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol. 2004;44:1268-1275. doi: 10.1016/j. jacc.2004.06.029.
198. Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD; VALIANT Investigators. Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010;122:597-602. doi: 10.1161/CIRCULATIONAHA.110.940619.
199. Reinier K, Stecker EC, Vickers C, Gunson K, Jui J, Chugh SS. Incidence of sudden cardiac arrest is higher in areas of low socioeconomic status: a prospective two year study in a large United States community. Resuscitation. 2006;70:186-192. doi: 10.1016/j. resuscitation.2005.11.018.
200. Chugh SS, Chung K, Zheng ZJ, John B, Titus JL. Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women. Am Heart J. 2003;146:635-639. doi: 10.1016/S0002-8703(03)00323-5.
201. Mäkikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Perkiömäki JS, Schmidt G, Huikuri HV. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006;97:480-484. doi: 10.1016/j.amjcard.2005.09.077.
202. Sankaranarayanan R, James MA, Nuta B, Townsend M, Kesavan S, Burtchaell S, Holloway R, Ewings P. Does atrial fibrillation beget ventricular fibrillation in patients with acute myocardial infarction Pacing Clin Electrophysiol. 2008;31:1612-1619. doi: 10.1111/j.1540-8159.2008.01234.x.
203. Stecker EC, Vickers C, Waltz J, Socoteanu C, John BT, Mariani R, McAnulty JH, Gunson K, Jui J, Chugh SS. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-1166. doi: 10.1016/j. jacc.2005.11.045.
204. Yu H, Pi-Hua F, Yuan W, Xiao-Feng L, Jun L, Zhi L, Sen L, Zhang S. Prediction of sudden cardiac death in patients after acute myocardial infarction using T-wave alternans: a prospective study. J Electrocardiol. 2012;45:60-65. doi: 10.1016/j.jelectrocard.2011.07.015.
205. Savopoulos C, Ziakas A, Hatzitolios A, Delivoria C, Kounanis A, Mylonas S, Tsougas M, Psaroulis D. Circadian rhythm in sudden cardiac death: a retrospective study of 2,665 cases. Angiology. 2006;57:197-204.
206. Moser DK, McKinley S, Dracup K, Chung ML. Gender differences in reasons patients delay in seeking treatment for acute myocardial infarction symptoms. Patient Educ Couns. 2005;56:45-54. doi: 10.1016/j. pec.2003.11.011.
207. Rosenfeld AG, Lindauer A, Darney BG. Understanding treatment-seeking delay in women with acute myocardial infarction: descriptions of decision-making patterns. Am J Crit Care. 2005;14:285-293.
208. Moser DK, Kimble LP, Alberts MJ, Alonzo A, Croft JB, Dracup K, Evenson KR, Go AS, Hand MM, Kothari RU, Mensah GA, Morris DL, Pancioli AM, Riegel B, Zerwic JJ. Reducing delay in seeking treatment by patients with acute coronary syndrome and stroke: a scientific statement from the American Heart Association Council on Cardiovascular Nursing and Stroke Council. Circulation. 2006;114:168-182. doi: 10.1161/CIRCULATIONAHA.106.176040.
209. Newman JD, Davidson KW, Ye S, Shaffer JA, Shimbo D, Muntner P. Gender differences in calls to 9-1-1 during an acute coronary syndrome. Am J Cardiol. 2013;111:58-62. doi: 10.1016/j.amjcard.2012.08.048.
210. Nguyen HL, Gore JM, Saczynski JS, Yarzebski J, Reed G, Spencer FA, Goldberg RJ. Age and sex differences and 20-year trends (1986 to 2005) in prehospital delay in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010;3:590-598. doi: 10.1161/CIRCOUTCOMES.110.957878.
211. Nguyen HL, Saczynski JS, Gore JM, Goldberg RJ. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2010;3:82-92. doi: 10.1161/CIRCOUTCOMES.109.884361.
212. Kaur R, Lopez V, Thompson DR. Factors influencing Hong Kong Chinese patients' decision-making in seeking early treatment for acute myocardial infarction. Res Nurs Health. 2006;29:636-646. doi: 10.1002/nur.20171.
213. DeVon HA, Saban KL, Garrett DK. Recognizing and responding to symptoms of acute coronary syndromes and stroke in women. J Obstet Gynecol Neonatal Nurs. 2011;40:372-382. doi: 10.1111/j.1552-6909.2011.01241.x.
214. DeVon HA. Promoting cardiovascular health in women across the life span. J Obstet Gynecol Neonatal Nurs. 2011;40:335-336. doi: 10.1111/j.1552-6909.2011.01235.x.
215. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2013;128:e481]. Circulation. 2013;127:e362-e425. doi: 10.1161/CIR.0b013e3182742cf6.
216. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;130:e433-434]. Circulation. 2014;130:e344-e426. doi: 10.1161/CIR.0000000000000134.
217. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients: Fibrinolytic Therapy Trialists' (FTT) Collaborative Group [published correction appears in Lancet. 1994;343:742]. Lancet. 1994;343:311-322.
218. White HD, Barbash GI, Modan M, Simes J, Diaz R, Hampton JR, Heikkilä J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T, Pehrsson K, Sandøe E, Wilcox RG, Verstraete M, von der Lippe G, Van de Werf F; Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke: the Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation. 1993;88(pt 1):2097-2103.
219. Woodfield SL, Lundergan CF, Reiner JS, Thompson MA, Rohrbeck SC, Deychak Y, Smith JO, Burton JR, McCarthy WF, Califf RM, White HD, Weaver WD, Topol EJ, Ross AM. Gender and acute myocardial infarction: is there a different response to thrombolysis J Am Coll Cardiol. 1997;29:35-42.
220. Tjandrawidjaja MC, Fu Y, Goodman SG, Van de Werf F, Granger CB, Armstrong PW; ASSENT-2 Investigators. The impact of gender on the treatment and outcomes of patients with early reinfarction after fibrinolysis: insights from ASSENT-2. Eur Heart J. 2003;24:1024-1034.
221. Mega JL, Morrow DA, Ostör E, Dorobantu M, Qin J, Antman EM, Braunwald E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction. Circulation. 2007;115:2822-2828. doi: 10.1161/CIRCULATIONAHA.106.679548.
222. Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke. 2000;31:1802-1811.
223. Karnash SL, Granger CB, White HD, Woodlief LH, Topol EJ, Califf RM. Treating menstruating women with thrombolytic therapy: insights from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. J Am Coll Cardiol. 1995;26:1651-1656.
224. Boersma E; Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779-788. doi: 10.1093/eurheartj/ehi810.
225. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchrowicz-Ochocki S, O'Neill WW. Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction. Am J Cardiol. 1995;75:987-992.
226. Tamis-Holland JE, Palazzo A, Stebbins AL, Slater JN, Boland J, Ellis SG, Hochman JS; GUSTO II-B Angioplasty Substudy Investigators. Benefits of direct angioplasty for women and men with acute myocardial infarction: results of the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes Angioplasty (GUSTO II-B) Angioplasty Substudy. Am Heart J. 2004;147:133-139.
227. Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in shortterm and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014;174:1822-1830. doi: 10.1001/jamainternmed.2014.4762.
228. Lansky AJ, Pietras C, Costa RA, Tsuchiya Y, Brodie BR, Cox DA, Aymong ED, Stuckey TD, Garcia E, Tcheng JE, Mehran R, Negoita M, Fahy M, Cristea E, Turco M, Leon MB, Grines CL, Stone GW. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation. 2005;111:1611-1618. doi: 10.1161/01.CIR.0000160362.55803.40.
229. Yu J, Mehran R, Grinfeld L, Xu K, Nikolsky E, Brodie BR, Witzenbichler B, Kornowski R, Dangas GD, Lansky AJ, Stone GW. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv. 2015;85:359-368. doi: 10.1002/ccd.25630.
230. Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW. A risk score to predict bleeding in patients with acute coronary syndromes. J Am Coll Cardiol. 2010;55:2556-2566. doi: 10.1016/j.jacc.2009.09.076.
231. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1999;341:1949-1956. doi: 10.1056/NEJM199912233412601.
232. Stefanini GG, Baber U, Windecker S, Morice MC, Sartori S, Leon MB, Stone GW, Serruys PW, Wijns W, Weisz G, Camenzind E, Steg PG, Smits PC, Kandzari D, Von Birgelen C, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Valgimigli M, Kastrati A, Chieffo A, Mehran R. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials [published correction appears in Lancet. 2013;382:1878]. Lancet. 2013;382:1879-1888. doi: 10.1016/S0140-6736(13)61782-1.
233. Kim C, Redberg RF, Pavlic T, Eagle KA. A systematic review of gender differences in mortality after coronary artery bypass graft surgery and percutaneous coronary interventions. Clin Cardiol. 2007;30:491-495. doi: 10.1002/clc.20000.
234. Bukkapatnam RN, Yeo KK, Li Z, Amsterdam EA. Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). Am J Cardiol. 2010;105:339-342. doi: 10.1016/j. amjcard.2009.09.035.
235. Vaccarino V, Abramson JL, Veledar E, Weintraub WS. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality in younger women. Circulation. 2002;105:1176-1181.
236. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC Jr, Pollack CV Jr, Gibler WB, Ohman EM; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-2104. doi: 10.1001/jama.292.17.2096.
237. O'Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Wallentin L, Windhausen F, Sabatine MS. Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71-80. doi: 10.1001/jama.300.1.71.
238. Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E. Benefit of an early invasive management strategy in women with acute coronary syndromes. JAMA. 2002;288:3124-3129.
239. Lagerqvist B, Säfström K, Ståhle E, Wallentin L, Swahn E; FRISC II Study Group Investigators. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men FRISC II Study Group Investigators. J Am Coll Cardiol. 2001;38:41-48.
240. Clayton TC, Pocock SJ, Henderson RA, Poole-Wilson PA, Shaw TR, Knight R, Fox KA. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction The impact of gender in the RITA 3 trial. Eur Heart J. 2004;25:1641-1650. doi: 10.1016/j.ehj.2004.07.032.
241. Lansky AJ, Costa RA, Mooney M, Midei MG, Lui HK, Strickland W, Mehran R, Leon MB, Russell ME, Ellis SG, Stone GW; TAXUS-IV Investigators. Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease. J Am Coll Cardiol. 2005;45:1180-1185. doi: 10.1016/j.jacc.2004.10.076.
242. Ng VG, Lansky AJ, Hermiller JB, Farhat N, Applegate RJ, Yaqub M, Sood P, Su X, Simonton CA, Sudhir K, Stone GW. Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial). Am J Cardiol. 2011;107:841-848. doi: 10.1016/j.amjcard.2010.10.068.
243. Solinas E, Nikolsky E, Lansky AJ, Kirtane AJ, Morice MC, Popma JJ, Schofer J, Schampaert E, Pucelikova T, Aoki J, Fahy M, Dangas GD, Moses JW, Cutlip DE, Leon MB, Mehran R. Gender-specific outcomes after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2007;50:2111-2116. doi: 10.1016/j.jacc.2007.06.056.
244. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190-1197. doi: 10.1016/S0140-6736(09)60552-3.
245. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375-2384. doi: 10.1056/NEJMoa1211585.
246. Akhter N, Milford-Beland S, Roe MT, Piana RN, Kao J, Shroff A. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J. 2009;157:141-148. doi: 10.1016/j.ahj.2008.08.012.
247. Lansky AJ, Mehran R, Cristea E, Parise H, Feit F, Ohman EM, White HD, Alexander KP, Bertrand ME, Desmet W, Hamon M, Stone GW. Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). Am J Cardiol. 2009;103:1196-1203. doi: 10.1016/j.amjcard.2009.01.030.
248. Alexander KP, Chen AY, Newby LK, Schwartz JB, Redberg RF, Hochman JS, Roe MT, Gibler WB, Ohman EM, Peterson ED; CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Investigators. Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation. 2006;114:1380-1387. doi: 10.1161/CIRCULATIONAHA.106.620815.
249. Koopman C, Vaartjes I, Heintjes EM, Spiering W, van Dis I, Herings RM, Bots ML. Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010. Eur Heart J. 2013;34:3198-3205. doi: 10.1093/eurheartj/eht368.
250. Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010;3:632-641. doi: 10.1161/CIRCOUTCOMES.109.906214.
251. Patel MR, Chen AY, Peterson ED, Newby LK, Pollack CV Jr, Brindis RG, Gibson CM, Kleiman NS, Saucedo JF, Bhatt DL, Gibler WB, Ohman EM, Harrington RA, Roe MT. Prevalence, predictors, and outcomes of patients with non-ST-segment elevation myocardial infarction and insignificant coronary artery disease: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative. Am Heart J. 2006;152:641-647. doi: 10.1016/j. ahj.2006.02.035.
252. Roe MT, Harrington RA, Prosper DM, Pieper KS, Bhatt DL, Lincoff AM, Simoons ML, Akkerhuis M, Ohman EM, Kitt MM, Vahanian A, Ruzyllo W, Karsch K, Califf RM, Topol EJ. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease: the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators. Circulation. 2000;102:1101-1106.
253. Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med. 2006;166:1391-1395. doi: 10.1001/archinte.166.13.1391.
254. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet. 1988;2:349-360.
255. Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849-1860.
256. Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients: Antiplatelet Trialists' Collaboration [published correction appears in BMJ. 1994;308:1540]. BMJ. 1994;308:81-106.
257. Hennekens CH, Hollar D, Baigent C. Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis. Nat Clin Pract Cardiovasc Med. 2006;3:4-5. doi: 10.1038/ncpcardio0420.
258. CURRENT-OASIS 7 Investigators; Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, Granger CB, Jolly S, Joyner CD, Rupprecht HJ, Widimsky P, Afzal R, Pogue J, Yusuf S. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes [published correction appears in N Engl J Med. 2010;363:1585]. N Engl J Med. 2010;363:930-942.
259. Berger JS, Bhatt DL, Cannon CP, Chen Z, Jiang L, Jones JB, Mehta SR, Sabatine MS, Steinhubl SR, Topol EJ, Berger PB. The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis. J Am Coll Cardiol. 2009;54:1935-1945. doi: 10.1016/j. jacc.2009.05.074.
260. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-2015. doi: 10.1056/NEJMoa0706482.
261. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-1057. doi: 10.1056/NEJMoa0904327.
262. Husted S, James SK, Bach RG, Becker RC, Budaj A, Heras M, Himmelmann A, Horrow J, Katus HA, Lassila R, Morais J, Nicolau JC, Steg PG, Storey RF, Wojdyla D, Wallentin L; PLATO Study Group. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J. 2014;35:1541-1550. doi: 10.1093/eurheartj/ehu075.
263. Boersma E, Harrington RA, Moliterno DJ, White H, Théroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials [published correction appears in Lancet. 2002;359:2120]. Lancet. 2002;359:189-198. doi: 10.1016/S0140-6736(02)07442-1.
264. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009;360:2176-2190. doi: 10.1056/NEJMoa0901316.
265. Dziewierz A, Siudak Z, Rakowski T, Kleczyski P, Dubiel JS, Dudek D. Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry). J Thromb Thrombolysis. 2013;36:240-246. doi: 10.1007/s11239-012-0826-3.
266. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA. 1996;276:811-815.
267. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA. 2004;292:89-96. doi: 10.1001/jama.292.1.89.
268. Antman EM, Morrow DA, McCabe CH, Murphy SA, Ruda M, Sadowski Z, Budaj A, López-Sendón JL, Guneri S, Jiang F, White HD, Fox KA, Braunwald E; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354:1477-1488. doi: 10.1056/NEJMoa060898.
269. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358:605-613.
270. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, Colombo A, Aylward PE, Cequier AR, Darius H, Desmet W, Ebrahimi R, Hamon M, Rasmussen LH, Rupprecht HJ, Hoekstra J, Mehran R, Ohman EM; ACUITY Investigators. Bivalirudin for patients with acute coronary syndromes. N Engl J Med. 2006;355:2203-2216. doi: 10.1056/NEJMoa062437.
271. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230. doi: 10.1056/NEJMoa0708191.
272. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA; OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295:1519-1530. doi: 10.1001/jama.295.13.joc60038.
273. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators; Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006;354:1464-1476.
274. A randomized trial of propranolol in patients with acute myocardial infarction, II: morbidity results. JAMA. 1983;250:2814-2819.
275. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 1981;304:801-807.
276. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335-371.
277. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients: The Beta-Blocker Pooling Project Research Group. Eur Heart J. 1988;9:8-16.
278. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial: the SAVE Investigators. N Engl J Med. 1992;327:669-677. doi: 10.1056/NEJM199209033271001.
279. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure: the Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993;342:821-828.
280. The TRAndolapril Cardiac Evaluation (TRACE) study: rationale, design, and baseline characteristics of the screened population: the Trace Study Group. Am J Cardiol. 1994;73:44C-50C.
281. Swedberg K, Held P, Kjekshus J, Rasmussen K, Rydén L, Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med. 1992;327:678-684. doi: 10.1056/NEJM199209033271002.
282. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [published correction appears in N Engl J Med. 2004;350:203]. N Engl J Med. 2003;349:1893-1906. doi: 10.1056/NEJMoa032292.
283. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials [published correction appears in JAMA. 1995;274:462]. JAMA. 1995;273:1450-1456.
284. Shekelle PG, Rich MW, Morton SC, Atkinson CS, Tu W, Maglione M, Rhodes S, Barrett M, Fonarow GC, Greenberg B, Heidenreich PA, Knabel T, Konstam MA, Steimle A, Warner Stevenson L. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41:1529-1538.
285. Barreras A, Gurk-Turner C. Angiotensin II receptor blockers. Proc (Bayl Univ Med Cent). 2003;16:123-126.
286. Sadjadi SA, McMillan JI, Jaipaul N, Blakely P, Hline SS. A comparative study of the prevalence of hyperkalemia with the use of angiotensinconverting enzyme inhibitors versus angiotensin receptor blockers. Ther Clin Risk Manag. 2009;5:547-552.
287. Sidorenkov G, Navis G. Safety of ACE inhibitor therapies in patients with chronic kidney disease. Expert Opin Drug Saf. 2014;13:1383-1395. doi: 10.1517/14740338.2014.951328.
288. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension. 2012;60:444-450. doi: 10.1161/HYPERTENSIONAHA.112.196352.
289. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
290. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial Investigators. N Engl J Med. 1996;335:1001-1009. doi: 10.1056/NEJM199610033351401.
291. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.
292. Truong QA, Murphy SA, McCabe CH, Armani A, Cannon CP; TIMI Study Group. Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circ Cardiovasc Qual Outcomes. 2011;4:328-336. doi: 10.1161/CIRCOUTCOMES.110.957720.
293. Gutierrez J, Ramirez G, Rundek T, Sacco RL. Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis. Arch Intern Med. 2012;172:909-919. doi: 10.1001/archinternmed.2012.2145.
294. Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, Waters DD. Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials. Am J Cardiol. 2015;115:447-453. doi: 10.1016/j.amjcard.2014.11.026.
295. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation [published correction appears in Circulation. 2015;131:e408]. Circulation. 2011;124:2458-2473. doi: 10.1161/CIR.0b013e318235eb4d.
296. EACPR Committee for Science Guidelines; Corra U, Piepoli MF, Carre F, Heuschmann P, Hoffmann U, Verschuren M, Halcox J, Giannuzzi P, Saner H, Wood D, Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, McGee H, Mendes M, Niebauer J, Zwisler AD, Schmid JP. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J. 2010;31:1967-1974.
297. Piepoli MF, Corrà U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, McGee H, Mendes M, Niebauer J, Zwisler AD, Schmid JP; Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation: a position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17:1-17. doi: 10.1097/HJR.0b013e3283313592.
298. Balady GJ, Williams MA, Ades PA, Bittner V, Comoss P, Foody JM, Franklin B, Sanderson B, Southard D. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2007;115:2675-2682. doi: 10.1161/CIRCULATIONAHA.106.180945.
299. Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, Tomaselli GF, Yancy CW. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation. 2011;124:2951-2960. doi: 10.1161/CIR.0b013e31823b21e2.
300. Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54:25-33. doi: 10.1016/j.jacc.2009.01.078.
301. Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation. 2011;123:2344-2352. doi: 10.1161/CIRCULATIONAHA.110.983536.
302. Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011:CD001800.
303. Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation. 2010;121:63-70. doi: 10.1161/CIRCULATIONAHA.109.876383.
304. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2011;124:e957]. Circulation. 2011;124:e652-e735. doi: 10.1161/CIR.0b013e31823c074e.
305. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [published correction appears in Circulation. 2012;125:e421]. Circulation. 2011;124:e574-e651. doi: 10.1161/CIR.0b013e31823ba622.
306. Drozda J Jr, Messer JV, Spertus J, Abramowitz B, Alexander K, Beam CT, Bonow RO, Burkiewicz JS, Crouch M, Goff DC Jr, Hellman R, James T 3rd, King ML, Machado EA Jr, Ortiz E, O'Toole M, Persell SD, Pines JM, Rybicki FJ, Sadwin LB, Sikkema JD, Smith PK, Torcson PJ, Wong JB. ACCF/AHA/AMA-PCPI 2011 performance measures for adults with coronary artery disease and hypertension: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement [published correction appears in Circulation. 2011;124:e39]. Circulation. 2011;124:248-270. doi: 10.1161/CIR.0b013e31821d9ef2.
307. Thomas RJ, King M, Lui K, Oldridge N, Pina IL, Spertus J. AACVPR/ACCF/AHA 2010 update: performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: a report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Clinical Performance Measures for Cardiac Rehabilitation). Circulation. 2010;122:1342-1350.
308. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB 3rd, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR Jr, Smith SC Jr, Spertus JA, Williams SV, Anderson JL. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [published correction appears in Circulation. 2014;129:e463]. Circulation. 2012;126:e354-e471. doi: 10.1161/CIR.0b013e318277d6a0.
309. Beckie TM, Beckstead JW. Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial. J Cardiopulm Rehabil Prev. 2010;30:147-156. doi: 10.1097/HCR.0b013e3181d0c2ce.
310. Daniels KM, Arena R, Lavie CJ, Forman DE. Cardiac rehabilitation for women across the lifespan. Am J Med. 2012;125:937e1-937e7. doi: 10.1016/j.amjmed.2011.10.028.
311. Turk-Adawi KI, Oldridge NB, Tarima SS, Stason WB, Shepard DS. Cardiac rehabilitation patient and organizational factors: what keeps patients in programs J Am Heart Assoc. 2013;2:e000418. doi: 10.1161/JAHA.113.000418.
312. Parashar S, Spertus JA, Tang F, Bishop KL, Vaccarino V, Jackson CF, Boyden TF, Sperling L. Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarction. Circulation. 2012;126:1587-1595. doi: 10.1161/CIRCULATIONAHA.111.088799.
313. Clark AM, King-Shier KM, Spaling MA, Duncan AS, Stone JA, Jaglal SB, Thompson DR, Angus JE. Factors influencing participation in cardiac rehabilitation programmes after referral and initial attendance: qualitative systematic review and meta-synthesis. Clin Rehabil. 2013;27:948-959. doi: 10.1177/0269215513481046.
314. Beckie TM, Mendonca MA, Fletcher GF, Schocken DD, Evans ME, Banks SM. Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial. J Cardiopulm Rehabil Prev. 2009;29:13-21; quiz 22-23. doi: 10.1097/HCR.0b013e31819276cb.
315. Sanderson BK, Shewchuk RM, Bittner V. Cardiac rehabilitation and women: what keeps them away J Cardiopulm Rehabil Prev. 2010;30:12-21. doi: 10.1097/HCR.0b013e3181c85859.
316. Beatty AL, Li S, Thomas L, Amsterdam EA, Alexander KP, Whooley MA. Trends in referral to cardiac rehabilitation after myocardial infarction: data from the National Cardiovascular Data Registry 2007 to 2012. J Am Coll Cardiol. 2014;63:2582-2583. doi: 10.1016/j.jacc.2014.03.030.
317. Casey E, Hughes JW, Waechter D, Josephson R, Rosneck J. Depression predicts failure to complete phase-II cardiac rehabilitation. J Behav Med. 2008;31:421-431. doi: 10.1007/s10865-008-9168-1.
318. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol. 2008;51:1619-1631. doi: 10.1016/j.jacc.2008.01.030.
319. Beckie TM, Beckstead JW, Schocken DD, Evans ME, Fletcher GF. The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: a randomized clinical trial. Int J Nurs Stud. 2011;48:3-12. doi: 10.1016/j.ijnurstu.2010.06.005.
320. Blumenthal JA, Sherwood A, Babyak MA, Watkins LL, Smith PJ, Hoffman BM, O'Hayer CV, Mabe S, Johnson J, Doraiswamy PM, Jiang W, Schocken DD, Hinderliter AL. Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study. J Am Coll Cardiol. 2012;60:1053-1063. doi: 10.1016/j.jacc.2012.04.040.
321. Davies P, Taylor F, Beswick A, Wise F, Moxham T, Rees K, Ebrahim S. Promoting patient uptake and adherence in cardiac rehabilitation. Cochrane Database Syst Rev. 2010:CD007131.
322. Taylor RS, Dalal H, Jolly K, Moxham T, Zawada A. Home-based versus centre-based cardiac rehabilitation. Cochrane Database Syst Rev. 2010:CD007130.
323. Grace SL, Gravely-Witte S, Kayaniyil S, Brual J, Suskin N, Stewart DE. A multisite examination of sex differences in cardiac rehabilitation barriers by participation status. J Womens Health (Larchmt). 2009;18:209-216. doi: 10.1089/jwh.2007.0753.
324. Brown TM, Hernandez AF, Bittner V, Cannon CP, Ellrodt G, Liang L, Peterson ED, Pinã IL, Safford MM, Fonarow GC; American Heart Association Get With The Guidelines Investigators. Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines Program. J Am Coll Cardiol. 2009;54:515-521. doi: 10.1016/j.jacc.2009.02.080.
325. Suaya JA, Shepard DS, Normand SL, Ades PA, Prottas J, Stason WB. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation. 2007;116:1653-1662. doi: 10.1161/CIRCULATIONAHA.107.701466.
326. McCarthy MM, Vaughan Dickson V, Chyun D. Barriers to cardiac rehabilitation in women with cardiovascular disease: an integrative review. J Cardiovasc Nurs. 2011;26:E1-E10. doi: 10.1097/JCN.0b013e3181f877e9.
327. Beckie TM. A behavior change intervention for women in cardiac rehabilitation. J Cardiovasc Nurs. 2006;21:146-153.
328. Beckie TM, Beckstead JW. The effects of a cardiac rehabilitation program tailored for women on global quality of life: a randomized clinical trial. J Womens Health (Larchmt). 2010;19:1977-1985. doi: 10.1089/jwh.2010.1937.
329. Beckie TM, Beckstead JW. The effects of a cardiac rehabilitation program tailored for women on their perceptions of health: a randomized clinical trial. J Cardiopulm Rehabil Prev. 2011;31:25-34. doi: 10.1097/HCR.0b013e3181f68acc.
330. Walters DL, Sarela A, Fairfull A, Neighbour K, Cowen C, Stephens B, Sellwood T, Sellwood B, Steer M, Aust M, Francis R, Lee CK, Hoffman S, Brealey G, Karunanithi M. A mobile phone-based care model for outpatient cardiac rehabilitation: the care assessment platform (CAP). BMC Cardiovasc Disord. 2010;10:5. doi: 10.1186/1471-2261-10-5.
331. Maddison R, Whittaker R, Stewart R, Kerr A, Jiang Y, Kira G, Carter KH, Pfaeffli L. HEART: heart exercise and remote technologies: a randomized controlled trial study protocol. BMC Cardiovasc Disord. 2011;11:26. doi: 10.1186/1471-2261-11-26.
332. Antypas K, Wangberg SC. An Internet-and mobile-based tailored intervention to enhance maintenance of physical activity after cardiac rehabilitation: short-term results of a randomized controlled trial. J Med Internet Res. 2014;16:e77. doi: 10.2196/jmir.3132.
333. McCall-Hosenfeld JS, Freund KM, Legault C, Jaramillo SA, Cochrane BB, Manson JE, Wenger NK, Eaton CB, McNeeley SG, Rodriguez BL, Bonds D. Sexual satisfaction and cardiovascular disease: the Women's Health Initiative. Am J Med. 2008;121:295-301. doi: 10.1016/j.amjmed.2007.11.013.
334. Brännström M, Kristofferzon ML, Ivarsson B, Nilsson UG, Svedberg P, Thylén I; SAMMI-Study Group. Sexual knowledge in patients with a myocardial infarction and their partners. J Cardiovasc Nurs. 2014;29:332-339. doi: 10.1097/JCN.0b013e318291ede6.
335. Steinke EE, Mosack V, Barnason S, Wright DW. Progress in sexual counseling by cardiac nurses, 1994 to 2009. Heart Lung. 2011;40:e15-e24. doi: 10.1016/j.hrtlng.2010.10.001.
336. Lindau ST, Abramsohn E, Gosch K, Wroblewski K, Spatz ES, Chan PS, Spertus J, Krumholz HM. Patterns and loss of sexual activity in the year following hospitalization for acute myocardial infarction (a United States National Multisite Observational Study). Am J Cardiol. 2012;109:1439-1444. doi: 10.1016/j.amjcard.2012.01.355.
337. Lindau ST, Abramsohn EM, Bueno H, D'Onofrio G, Lichtman JH, Lorenze NP, Mehta Sanghani R, Spatz ES, Spertus JA, Strait K, Wroblewski K, Zhou S, Krumholz HM. Sexual activity and counseling in the first month after acute myocardial infarction among younger adults in the United States and Spain: a prospective, observational study. Circulation. 2014;130:2302-2309. doi: 10.1161/CIRCULATIONAHA.114.012709.
338. Levine GN, Steinke EE, Bakaeen FG, Bozkurt B, Cheitlin MD, Conti JB, Foster E, Jaarsma T, Kloner RA, Lange RA, Lindau ST, Maron BJ, Moser DK, Ohman EM, Seftel AD, Stewart WJ; on behalf of the American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Quality of Care and Outcomes Research. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1058-1072. doi: 10.1161/CIR.0b013e3182447787.
339. Steinke EE, Jaarsma T, Barnason SA, Byrne M, Doherty S, Dougherty CM, Fridlund B, Kautz DD, Mårtensson J, Mosack V, Moser DK; on behalf of the Council on Cardiovascular and Stroke Nursing of the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). Sexual counseling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). Circulation. 2013;128:2075-2096. doi: 10.1161/CIR.0b013e31829c2e53.
340. Moscucci M, Fox KA, Cannon CP, Klein W, López-Sendón J, Montalescot G, White K, Goldberg RJ. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1815-1823.
341. Ahmed B, Piper WD, Malenka D, VerLee P, Robb J, Ryan T, Herne M, Phillips W, Dauerman HL. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv. 2009;2:423-429. doi: 10.1161/CIRCINTERVENTIONS.109.860494.
342. Ndrepepa G, Berger PB, Mehilli J, Seyfarth M, Neumann FJ, Schömig A, Kastrati A. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol. 2008;51:690-697. doi: 10.1016/j.jacc.2007.10.040.
343. Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009;2:1074-1082. doi: 10.1016/j.jcin.2009.09.002.
344. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774-782. doi: 10.1161/CIRCULATIONAHA.106.612812.
345. Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lincoff AM, Stone GW. Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach. Eur Heart J. 2007;28:1936-1945. doi: 10.1093/eurheartj/ehm194.
346. Wall TC, Califf RM, Ellis SG, Sigmon K, Kereiakes D, George BS, Samaha J, Sane D, Stump DC, Stack RS, Topol EJ. Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy: the TAMI Study Group. J Am Coll Cardiol. 1993;21:597-603.
347. Capodanno D, Ferreiro JL, Angiolillo DJ. Antiplatelet therapy: new pharmacological agents and changing paradigms. J Thromb Haemost. 2013;11(suppl 1):316-329. doi: 10.1111/jth.12219.
348. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, Grundy SM, Hiratzka L, Jones D, Krumholz HM, Mosca L, Pasternak RC, Pearson T, Pfeffer MA, Taubert KA. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute [published correction appears in Circulation. 2006;113:e847]. Circulation. 2006;113:2363-2372. doi: 10.1161/CIRCULATIONAHA.106.174516.
349. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC Jr. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2011;123:e627]. Circulation. 2011;123:e426-e579. doi: 10.1161/CIR.0b013e318212bb8b.
350. Daugherty SL, Thompson LE, Kim S, Rao SV, Subherwal S, Tsai TT, Messenger JC, Masoudi FA. Patterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2013;61:2070-2078. doi: 10.1016/j.jacc.2013.02.030.
351. Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, Jorgensen JP, Mazzaferri EL Jr, Jolly SS, Jacobs A, Newby LK, Gibson CM, Kong DF, Mehran R, Waksman R, Gilchrist IC, McCourt BJ, Messenger JC, Peterson ED, Harrington RA, Krucoff MW. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014;7:857-867. doi: 10.1016/j.jcin.2014.04.007.
352. Hess CN, McCoy LA, Duggirala HJ, Tavris DR, O'Callaghan K, Douglas PS, Peterson ED, Wang TY. Sex-based differences in outcomes after percutaneous coronary intervention for acute myocardial infarction: a report from TRANSLATE-ACS. J Am Heart Assoc. 2014;3:e000523. doi: 10.1161/JAHA.113.000523.
353. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA, Godfrey E, White HD, Lim J, LeJemtel T. Cardiogenic shock complicating acute myocardial infarction: etiologies, management and outcome: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1063-1070.
354. Wong SC, Sanborn T, Sleeper LA, Webb JG, Pilchik R, Hart D, Mejnartowicz S, Antonelli TA, Lange R, French JK, Bergman G, LeJemtel T, Hochman JS. Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1077-1083.
355. Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, White HD, Hochman JS. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1084-1090.
356. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM; Investigators in the National Registry of Myocardial Infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933-939. doi: 10.1067/mhj.2001.115295.
357. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448-454. doi: 10.1001/jama.294.4.448.
358. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-634. doi: 10.1056/NEJM199908263410901.
359. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, Dens J, Dzavik V, Palmeri ST, Webb JG, Goldberger M, Hochman JS. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1123-1129.
360. Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, Lopez-Sendon J; Global Registry of Acute Coronary Events; GRACE Investigators. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002;90:838-842.
361. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD; SHOCK Investigators. Early revascularization and longterm survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006;295:2511-2515. doi: 10.1001/jama.295.21.2511.
362. Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, De Bruyne B, Farhat N, Niess G, Jankovic I, Lazar D, Xu K, Fahy M, Serruys PW, Stone GW. Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(suppl):S62-S72. doi: 10.1016/j.jcmg.2012.02.003.
363. Dey S, Flather MD, Devlin G, Brieger D, Gurfinkel EP, Steg PG, Fitzgerald G, Jackson EA, Eagle KA; Global Registry of Acute Coronary Events Investigators. Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart. 2009;95:20-26. doi: 10.1136/hrt.2007.138537.
364. Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, Tei C, Miyazaki S, Sonoda M, Tsuchihashi K, Yamagishi M, Ikeda Y, Shirai M, Hiraoka H, Inoue T, Saito F, Ogawa H; Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Sex differences in early mortality of patients undergoing primary stenting for acute myocardial infarction. Circ J. 2006;70:217-221.
365. Al-Fiadh AH, Andrianopoulos N, Farouque O, Yan BP, Duffy SJ, Charter K, Tongyoo S, New G, Yip T, Brennan A, Proimos G, Reid CM, Ajani AE, Clark DJ; Melbourne Interventional Group. Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes. Int J Cardiol. 2011;151:195-199. doi: 10.1016/j. ijcard.2010.05.018.
366. Mega JL, Hochman JS, Scirica BM, Murphy SA, Sloan S, McCabe CH, Merlini P, Morrow DA. Clinical features and outcomes of women with unstable ischemic heart disease: observations from Metabolic Efficiency With Ranolazine for less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36). Circulation. 2010;121:1809-1817. doi: 10.1161/CIRCULATIONAHA.109.897231.
367. Kaul P, Chang WC, Westerhout CM, Graham MM, Armstrong PW. Differences in admission rates and outcomes between men and women presenting to emergency departments with coronary syndromes. CMAJ. 2007;177:1193-1199. doi: 10.1503/cmaj.060711.
368. Oqueli E, Baker L, Carroll A, Hiscock M, Dick R. Percutaneous coronary intervention in women: in-hospital clinical outcome: experience from a single private institution in Melbourne. Heart Lung Circ. 2008;17(suppl 4):S55-S62. doi: 10.1016/j.hlc.2008.08.002.
369. Jeger RV, Urban P, Harkness SM, Tseng CH, Stauffer JC, Lejemtel TH, Sleeper LA, Pfisterer ME, Hochman JS. Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: a pooled analysis of trials. Acute Card Care. 2011;13:14-20. doi: 10.3109/17482941.2010.538696.
370. Williams MS, Weiss EJ, Sabatine MS, Simon DI, Bahou WF, Becker LC, Parise LV, Dauerman HL, French PA, Smyth SS, Becker RC; 2010 Platelet Colloquium Participants. Genetic regulation of platelet receptor expression and function: application in clinical practice and drug development. Arterioscler Thromb Vasc Biol. 2010;30:2372-2384. doi: 10.1161/ATVBAHA.110.218131.
371. Berthillot C, Stephan D, Chauvin M, Roul G. In-hospital complications after invasive strategy for the management of non STEMI: women fare as well as men. BMC Cardiovasc Disord. 2010;10:31. doi: 10.1186/1471-2261-10-31.
372. Thompson CR, Buller CE, Sleeper LA, Antonelli TA, Webb JG, Jaber WA, Abel JG, Hochman JS. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry: SHould we use emergently revascularize Occluded Coronaries in cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1104-1109.
373. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, Dzavik V, Greenberg M, Menegus M, Connery C, Hochman JS. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock J Am Coll Cardiol. 2000;36(suppl A):1117-1122.
374. Menon V, Webb JG, Hillis LD, Sleeper LA, Abboud R, Dzavik V, Slater JN, Forman R, Monrad ES, Talley JD, Hochman JS. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry: SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK J Am Coll Cardiol. 2000;36(suppl A):1110-1116.
375. Yosefy C, Beeri R, Guerrero JL, Vaturi M, Scherrer-Crosbie M, Handschumacher MD, Levine RA. Mitral regurgitation after anteroapical myocardial infarction: new mechanistic insights. Circulation. 2011;123:1529-1536. doi: 10.1161/CIRCULATIONAHA.110.977843.
376. Chen Q, Darlymple-Hay MJ, Alexiou C, Ohri SK, Haw MP, Livesey SA, Monro JL. Mitral valve surgery for acute papillary muscle rupture following myocardial infarction. J Heart Valve Dis. 2002;11:27-31.
377. Nishimura RA, Gersh BJ, Schaff HV. The case for an aggressive surgical approach to papillary muscle rupture following myocardial infarction: "from paradise lost to paradise regained". Heart. 2000;83:611-613.
378. Crenshaw BS, Granger CB, Birnbaum Y, Pieper KS, Morris DC, Kleiman NS, Vahanian A, Califf RM, Topol EJ. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction: GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation. 2000;101:27-32.
379. Califf RM, White HD, Van de Werf F, Sadowski Z, Armstrong PW, Vahanian A, Simoons ML, Simes RJ, Lee KL, Topol EJ. One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial: GUSTO-I Investigators. Circulation. 1996;94:1233-1238.
380. Lemery R, Smith HC, Giuliani ER, Gersh BJ. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol. 1992;70:147-151.
381. Patel MR, Meine TJ, Lindblad L, Griffin J, Granger CB, Becker RC, Van de Werf F, White H, Califf RM, Harrington RA. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Am Heart J. 2006;151:316-322. doi: 10.1016/j.ahj.2005.04.014.
382. Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, Tiefenbrunn AJ, Bowlby LJ, Rogers WJ. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996;27:1321-1326.
383. Birnbaum Y, Chamoun AJ, Anzuini A, Lick SD, Ahmad M, Uretsky BF. Ventricular free wall rupture following acute myocardial infarction. Coron Artery Dis. 2003;14:463-470. doi: 10.1097/01.mca.0000085885.61165.f9.
384. Honan MB, Harrell FE Jr, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol. 1990;16:359-367.
385. McMullan MH, Maples MD, Kilgore TL Jr, Hindman SH. Surgical experience with left ventricular free wall rupture. Ann Thorac Surg. 2001;71:1894-1898.
386. López-Sendón J, González A, López de Sá E, Coma-Canella I, Roldán I, Domínguez F, Maqueda I, Martín Jadraque L. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol. 1992;19:1145-1153.
387. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes: the GUSTO Investigators. Circulation. 1998;98:2567-2573.
388. Mehta RH, Starr AZ, Lopes RD, Hochman JS, Widimsky P, Pieper KS, Armstrong PW, Granger CB; APEX AMI Investigators. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA. 2009;301:1779-1789. doi: 10.1001/jama.2009.600.
389. Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, Xie JX, Liu LS; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebocontrolled trial. Lancet. 2005;366:1622-1632.
390. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies: Antiarrhythmics vs Implantable Defibrillator study, Cardiac Arrest Study Hamburg, Canadian Implantable Defibrillator Study. Eur Heart J. 2000;21:2071-2078. doi: 10.1053/euhj.2000.2476.
391. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J. 1994;127(pt 2):1139-1144.
392. Wever EF, Hauer RN, van Capelle FL, Tijssen JG, Crijns HJ, Algra A, Wiesfeld AC, Bakker PF, Robles de Medina EO. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation. 1995;91:2195-2203.
393. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130:94-125. doi: 10.1161/CIR.0000000000000056.
394. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure [published correction appears in N Engl J Med. 2005;352:2146]. N Engl J Med. 2005;352:225-237. doi: 10.1056/NEJMoa043399.
395. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ; MADIT-II Research Group. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007;18:833-838. doi: 10.1111/j.1540-8167.2007.00857.x.
396. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverterdefibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517-1524. doi: 10.1001/jama.298.13.1517.
397. Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H; MADIT II Investigators. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005;16:1265-1270. doi: 10.1111/j.1540-8167.2005.00224.x.
398. Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. J Cardiovasc Electrophysiol. 2008;19:720-724. doi: 10.1111/j.1540-8167.2008.01129.x.
399. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169:1500-1506. doi: 10.1001/archinternmed.2009.255.
400. Santangeli P, Pelargonio G, Dello Russo A, Casella M, Bisceglia C, Bartoletti S, Santarelli P, Di Biase L, Natale A. Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm. 2010;7:876-882. doi: 10.1016/j.hrthm.2010.03.042.
401. Zabarovskaja S, Gadler F, Braunschweig F, Ståhlberg M, Hörnsten J, Linde C, Lund LH. Women have better long-term prognosis than men after cardiac resynchronization therapy. Europace. 2012;14:1148-1155. doi: 10.1093/europace/eus039.
402. Lopes RD, Elliott LE, White HD, Hochman JS, Van de Werf F, Ardissino D, Nielsen TT, Weaver WD, Widimsky P, Armstrong PW, Granger CB. Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. Eur Heart J. 2009;30:2019-2028. doi: 10.1093/eurheartj/ehp213.
403. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [published correction appears in Circulation. 2014;130:e272-e274]. Circulation. 2014;130:e199-e267. doi: 10.1161/CIR.0000000000000041.
404. Meine TJ, Al-Khatib SM, Alexander JH, Granger CB, White HD, Kilaru R, Williams K, Ohman EM, Topol E, Califf RM. Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J. 2005;149:670-674. doi: 10.1016/j.ahj.2004.07.035.
405. Clemmensen P, Bates ER, Califf RM, Hlatky MA, Aronson L, George BS, Lee KL, Kereiakes DJ, Gacioch G, Berrios E, Topol EJ, The TAMI Study Group. Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy: TAMI Study Group. Am J Cardiol. 1991;67:225-230.
406. Berger PB, Ryan TJ. Inferior myocardial infarction: high-risk subgroups. Circulation. 1990;81:401-411.
407. Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW, Kudenchuk PJ, Ornato JP, McNally B, Silvers SM, Passman RS, White RD, Hess EP, Tang W, Davis D, Sinz E, Morrison LJ. Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [published corrections appear in Circulation. 2011;123:e236 and Circulation. 2013;128:e480]. Circulation. 2010;122(suppl 3):S729-S767. doi: 10.1161/CIRCULATIONAHA. 110.970988.
408. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. doi: 10.1161/CIR.0b013e318276ce9b.
409. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA; GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004;291:2727-2733. doi: 10.1001/jama.291.22.2727.
410. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
411. Karounos M, Chang AM, Robey JL, Sease KL, Shofer FS, Follansbee C, Hollander JE. TIMI risk score: does it work equally well in both males and females Emerg Med J. 2007;24:471-474. doi: 10.1136/emj.2007.048207.
412. Sinnecker D, Huster KM, Müller A, Dommasch M, Hapfelmeier A, Gebhardt J, Hnatkova K, Laugwitz KL, Malik M, Barthel P, Schmidt G. Sex differences in the non-invasive risk stratification and prognosis after myocardial infarction. J Electrocardiol. 2014;47:874-880. doi: 10.1016/j.jelectrocard.2014.08.010.
413. Malmberg K, Yusuf S, Gerstein HC, Brown J, Zhao F, Hunt D, Piegas L, Calvin J, Keltai M, Budaj A. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation. 2000;102:1014-1019.
414. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham study [published correction appears in JAMA. 1989;261:1884]. JAMA. 1988;260:3456-3460.
415. Andrikopoulos GK, Tzeis SE, Pipilis AG, Richter DJ, Kappos KG, Stefanadis CI, Toutouzas PK, Chimonas ET; Investigators of the Hellenic Study of AMI. Younger age potentiates post myocardial infarction survival disadvantage of women. Int J Cardiol. 2006;108:320-325. doi: 10.1016/j.ijcard.2005.05.016.
416. Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS, Agarwal P, Santra M, Bidyasar S, Lichtman JH, Wenger NK, Vaccarino V; PREMIER Registry Investigators. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med. 2006;166:876-883. doi: 10.1001/archinte.166.8.876.
417. Vaccarino V, Shah AJ, Rooks C, Ibeanu I, Nye JA, Pimple P, Salerno A, D'Marco L, Karohl C, Bremner JD, Raggi P. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med. 2014;76:171-180. doi: 10.1097/PSY.0000000000000045.
418. Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; on behalf of the American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129:1350-1369. doi: 10.1161/CIR.0000000000000019.
419. Beckie TM, Fletcher G, Groer MW, Kip KE, Ji M. Biopsychosocial health disparities among young women enrolled in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2015;35:103-113. doi: 10.1097/HCR.0000000000000095.
420. Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA, Vaccarino V. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: the NHLBI-sponsored WISE study. Arch Gen Psychiatry. 2006;63:874-880. doi: 10.1001/archpsyc.63.8.874.
421. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease [published correction appears in JAMA Psychiatry. 2015;72:851]. Arch Gen Psychiatry. 2008;65:62-71. doi: 10.1001/archgenpsychiatry.2007.4.
422. Frasure-Smith N, Lespérance F, Juneau M, Talajic M, Bourassa MG. Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med. 1999;61:26-37.
423. Orth-Gomér K, Wamala SP, Horsten M, Schenck-Gustafsson K, Schneiderman N, Mittleman MA. Marital stress worsens prognosis in women with coronary heart disease: the Stockholm Female Coronary Risk Study. JAMA. 2000;284:3008-3014.
424. Wang HX, Leineweber C, Kirkeeide R, Svane B, Schenck-Gustafsson K, Theorell T, Orth-Gomér K. Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women; the Stockholm Female Coronary Angiography Study. J Intern Med. 2007;261:245-254. doi: 10.1111/j.1365-2796.2006.01759.x.
425. Bucholz EM, Strait KM, Dreyer RP, Geda M, Spatz ES, Bueno H, Lichtman JH, D'Onofrio G, Spertus JA, Krumholz HM. Effect of low perceived social support on health outcomes in young patients with acute myocardial infarction: results from the VIRGO (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients) study. J Am Heart Assoc. 2014;3:e001252. doi: 10.1161/JAHA.114.001252.
426. Dreyer RP, Wang Y, Strait KM, Lorenze NP, D'Onofrio G, Bueno H, Lichtman JH, Spertus JA, Krumholz HM. Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the VIRGO study. Circulation. 2015;131:1971-1980. doi: 10.1161/CIRCULATIONAHA.114.014503.
427. Samad Z, Boyle S, Ersboll M, Vora AN, Zhang Y, Becker RC, Williams R, Kuhn C, Ortel TL, Rogers JG, O'Connor CM, Velazquez EJ, Jiang W; REMIT Investigators. Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study [published correction appears in J Am Coll Cardiol. 2014;64:2438]. J Am Coll Cardiol. 2014;64:1669-1678. doi: 10.1016/j.jacc.2014.04.087.
428. Wei J, Rooks C, Ramadan R, Shah AJ, Bremner JD, Quyyumi AA, Kutner M, Vaccarino V. Meta-analysis of mental stress-induced myocardial ischemia and subsequent cardiac events in patients with coronary artery disease. Am J Cardiol. 2014;114:187-192. doi: 10.1016/j. amjcard.2014.04.022.
429. Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ, Coleman RE, Hanson M, Babyak M, Thyrum ET, Krantz DS, O'Connor C. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life: association and hemodynamic features. Circulation. 1995;92:2102-2108.
430. Wei J, Pimple P, Shah AJ, Rooks C, Bremner JD, Nye JA, Ibeanu I, Murrah N, Shallenberger L, Raggi P, Vaccarino V. Depressive symptoms are associated with mental stress-induced myocardial ischemia after acute myocardial infarction. PLoS One. 2014;9:e102986. doi: 10.1371/journal.pone.0102986.
431. Burg MM, Meadows J, Shimbo D, Davidson KW, Schwartz JE, Soufer R. Confluence of depression and acute psychological stress among patients with stable coronary heart disease: effects on myocardial perfusion. J Am Heart Assoc. 2014;3:e000898. doi: 10.1161/JAHA.114.000898.
432. Wenger NK. Are we there yet Closing the gender gap in coronary heart disease recognition, management and outcomes. Expert Rev Cardiovasc Ther. 2013;11:1447-1450. doi: 10.1586/14779072.2013.845526.